ARCHIVES

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Nine Saturation Program Planning Contracts Approved

May 9, 1975

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

HHS: Gallo Committed Scientific Misconduct In AIDS Virus Discovery

January 8, 1993

NCI Cooperative Group Clinical Trials Approved

August 28, 2009

Organ Systems Programs “Filling the Gaps” With Targeted Research

January 23, 1987

Freement Lists Steps For Dealing With Disadvantaged

September 7, 1990